Kyle Melin to Middle Aged
This is a "connection" page, showing publications Kyle Melin has written about Middle Aged.
Connection Strength
0.292
-
Rodr?guez Nazario I, Vil? LM, Melin K. Feasibility and acceptability of incorporating telemedicine into pharmacy services in the rheumatology clinics of the School of Medicine of the University of Puerto Rico. Am J Health Syst Pharm. 2026 Apr 22; 83(9):e341-e348.
Score: 0.083
-
Melin K, Hilera-Botet CR, Vega-V?lez D, Salgado-Crespo VM, Santiago D, Hern?ndez-Agosto J, Mu?oz-Burgos A, Cajigas Z, Mart?nez-V?lez JJ, Rodr?guez-D?az CE. Readiness to provide pharmaceutical care to transgender patients: Perspectives from pharmacists and transgender individuals. J Am Pharm Assoc (2003). 2019 Sep - Oct; 59(5):651-659.
Score: 0.051
-
Melin K, Moon JY, Qi Q, Hernandez-Suarez DF, Duconge J, Hua S, Gonzalez S, Zeng D, Kaplan RC. Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohort. Pharmacogenomics. 2019 01; 20(2):75-83.
Score: 0.050
-
Melin K, Conte-Schmidt N, Mart?nez-Arroyo K, Rosa-P?rez K, Soto-Avil?s AE, Hern?ndez-Mu?oz JJ. Knowledge and Perceptions of E-cigarettes and the Motivations for their Use: Talking to Smokers (E-cigarettes and/or Conventional Cigarettes) and Non-smokers in Puerto Rico. P R Health Sci J. 2018 09; 37(3):148-154.
Score: 0.049
-
Nu?ez-Medina HJ, Monero M, Torres LM, Leal E, Gonzalez-Sepulveda L, Mayor ?M, Renta JY, Gonz?lez-Garc?a ER, Gonz?lez A, Melin K, Scott SA, Rua?o G, Hernandez-Suarez DF, Duconge J. Implementing a pharmacogenomic-driven algorithm to guide antiplatelet therapy among Caribbean Hispanics: a non-randomised clinical trial. BMJ Open. 2024 09 05; 14(9):e084119.
Score: 0.018
-
Santiago D, Rosario Y, Melin K, Duconge J, Roman L, Gonzalez A, Venkataramanan R. Brand-to-Generic Substitution of Buprenorphine/Naloxone Sublingual Film in Puerto Rico: A Case Study. P R Health Sci J. 2021 12; 40(4):192-194.
Score: 0.015
-
Duconge J, Santiago E, Hernandez-Suarez DF, Moner? M, L?pez-Reyes A, Rosario M, Renta JY, Gonz?lez P, Ileana Fern?ndez-Morales L, Antonio V?lez-Figueroa L, Arce O, Mar?n-Maldonado F, Nu?ez H, Melin K, Scott SA, Rua?o G. Pharmacogenomic polygenic risk score for clopidogrel responsiveness among Caribbean Hispanics: A candidate gene approach. Clin Transl Sci. 2021 11; 14(6):2254-2266.
Score: 0.015
-
Hernandez-Suarez DF, Scott SA, Tomey MI, Melin K, Lopez-Candales A, Buckley CE, Duconge J. Clinical determinants of clopidogrel responsiveness in a heterogeneous cohort of Puerto Rican Hispanics. Ther Adv Cardiovasc Dis. 2017 Sep; 11(9):235-241.
Score: 0.011